Clinical study of Shenyuan Yiqi Huoxue Capsule on cardiopulmonary motor function and quality of life in patients with Ischemic Cardiomyopathy
- Conditions
- Ischemic cardiomyopathy
- Registration Number
- ITMCTR2200006813
- Lead Sponsor
- Beijing Hospital of Traditional Chinese Medicine Affiliated to Capital Medical University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- Not specified
? Meeting the diagnostic criteria of ischemic cardiomyopathy, and the TCM syndrome differentiation type belongs to Qi deficiency and blood stasis type.
? Recent or previous echocardiography showed left ventricular ejection fraction (LVEF)<40%, NYHA cardiac function grade II-III.
? Coronary angiography or CT showed multiple vessel stenosis, or a history of coronary revascularization, or a clear history of myocardial infarction.
? Between the ages of 18 and 75.
? Patients and family members gave informed consent and signed informed consent.
? Other causes of heart failure or enlargement.
? NYHA cardiac function grade IV.
? Pregnant and lactation patients.
? Severe cardiogenic shock and severe hypotension.
? Severe anemia, coagulopathy.
? Severe brain, liver, renal dysfunction, limb movement disorder;
? The presence of allergy or hypersensitivity to the ingredients involved in the study drug.
? Recently participated in clinical observation of other drugs or taken preparations similar to traditional Chinese medicine.
If one of the above is combined, it is excluded from the group.
Study & Design
- Study Type
- Interventional study
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method